These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36894193)

  • 61. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
    Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
    Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
    Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 68. Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.
    Ames PRJ; Merashli M; Bucci T; Pastori D; Pignatelli P; Arcaro A; Gentile F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527000
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
    Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
    Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres.
    Moschetti L; Dal Pozzolo L; Le Guern V; Morel N; Yelnik CM; Lambert M; Hachulla E; Benhamou Y; Nalli C; Fredi M; Franceschini F; Andreoli L; Costedoat-Chalumeau N; Tincani A
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):19-26. PubMed ID: 35349408
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
    Balbi GGM; Ahmadzadeh Y; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Lopez-Pedrera C; Fortin PR; Wahl D; Gerosa M; de Jesús GR; Ji L; Atsumi T; Efthymiou M; Branch DW; Nalli C; Rodriguez Almaraz E; Petri M; Cervera R; Knight JS; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Roubey R; Erkan D; de Andrade DCO;
    Rheumatology (Oxford); 2024 Mar; 63(3):772-779. PubMed ID: 37307082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin.
    Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG
    Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.
    Arnaud L; Mathian A; Ruffatti A; Erkan D; Tektonidou M; Cervera R; Forastiero R; Pengo V; Lambert M; Martinez-Zamora MA; Balasch J; Zuily S; Wahl D; Amoura Z
    Autoimmun Rev; 2014 Mar; 13(3):281-91. PubMed ID: 24189281
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study.
    Ogata Y; Fujieda Y; Sugawara M; Sato T; Ohnishi N; Kono M; Kato M; Oku K; Amengual O; Atsumi T
    Rheumatology (Oxford); 2021 Mar; 60(3):1331-1337. PubMed ID: 32944779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.